Tradename: BOOSTRIX

Proper Name: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed

Indication: To include data on safety and the immune responses to BOOSTRIX when administered concomitantly with Zoster Vaccine Recombinant, Adjuvanted (SHINGRIX).    

BOOSTRIX is a vaccine indicated for:

Active booster immunization against tetanus, diphtheria, and pertussis in individuals aged 10 years and older. Immunization during the third trimester of pregnancy to prevent pertussis in infants younger than 2 months of age.

Approval Date: 06/14/2023

Manufacturer: GlaxoSmithKline Biologicals